annual FCF:
-$462.03M-$136.32M(-41.85%)Summary
- As of today (July 3, 2025), MDGL annual free cash flow is -$462.03 million, with the most recent change of -$136.32 million (-41.85%) on December 31, 2024.
- During the last 3 years, MDGL annual FCF has fallen by -$277.91 million (-150.93%).
- MDGL annual FCF is now -1957.65% below its all-time high of $24.87 million, reached on December 31, 2007.
Performance
MDGL Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$88.89M+$15.79M(+15.08%)Summary
- As of today (July 3, 2025), MDGL quarterly free cash flow is -$88.89 million, with the most recent change of +$15.79 million (+15.08%) on March 31, 2025.
- Over the past year, MDGL quarterly FCF has increased by +$60.62 million (+40.55%).
- MDGL quarterly FCF is now -231.68% below its all-time high of $67.51 million, reached on December 31, 2007.
Performance
MDGL quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$401.41M+$60.62M(+13.12%)Summary
- As of today (July 3, 2025), MDGL TTM free cash flow is -$401.41 million, with the most recent change of +$60.62 million (+13.12%) on March 31, 2025.
- Over the past year, MDGL TTM FCF has dropped by -$10.29 million (-2.63%).
- MDGL TTM FCF is now -1424.56% below its all-time high of $30.31 million, reached on June 30, 2016.
Performance
MDGL TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
MDGL Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -41.9% | +40.5% | -2.6% |
| 3 y3 years | -150.9% | -77.9% | -110.6% |
| 5 y5 years | -1005.5% | -188.4% | -409.3% |
MDGL Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -150.9% | at low | -54.7% | +40.5% | -99.5% | +13.1% |
| 5 y | 5-year | -1005.5% | at low | -266.3% | +40.5% | -409.3% | +13.1% |
| alltime | all time | -1957.7% | at low | -231.7% | +40.5% | -1424.6% | +13.1% |
MDGL Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$88.89M(-15.1%) | -$401.41M(-13.1%) |
| Dec 2024 | -$462.03M(+41.9%) | -$104.68M(+54.5%) | -$462.03M(+5.4%) |
| Sep 2024 | - | -$67.76M(-51.6%) | -$438.32M(-3.8%) |
| Jun 2024 | - | -$140.08M(-6.3%) | -$455.82M(+16.5%) |
| Mar 2024 | - | -$149.51M(+84.7%) | -$391.12M(+20.1%) |
| Dec 2023 | -$325.71M(+44.7%) | -$80.97M(-5.0%) | -$325.71M(+7.4%) |
| Sep 2023 | - | -$85.26M(+13.1%) | -$303.28M(+9.4%) |
| Jun 2023 | - | -$75.38M(-10.4%) | -$277.13M(+6.9%) |
| Mar 2023 | - | -$84.10M(+43.7%) | -$259.21M(+15.2%) |
| Dec 2022 | -$225.07M(+22.2%) | -$58.54M(-0.9%) | -$225.07M(+4.8%) |
| Sep 2022 | - | -$59.10M(+2.9%) | -$214.69M(+6.7%) |
| Jun 2022 | - | -$57.46M(+15.0%) | -$201.20M(+5.6%) |
| Mar 2022 | - | -$49.97M(+3.7%) | -$190.62M(+3.5%) |
| Dec 2021 | -$184.13M(+16.6%) | -$48.16M(+5.6%) | -$184.13M(-3.6%) |
| Sep 2021 | - | -$45.61M(-2.7%) | -$190.92M(-1.2%) |
| Jun 2021 | - | -$46.88M(+7.8%) | -$193.17M(+13.3%) |
| Mar 2021 | - | -$43.47M(-20.9%) | -$170.55M(+8.0%) |
| Dec 2020 | -$157.90M(+277.8%) | -$54.96M(+14.8%) | -$157.90M(+36.9%) |
| Sep 2020 | - | -$47.85M(+97.2%) | -$115.35M(+46.3%) |
| Jun 2020 | - | -$24.27M(-21.3%) | -$78.82M(+19.3%) |
| Mar 2020 | - | -$30.82M(+148.2%) | -$66.10M(+58.1%) |
| Dec 2019 | -$41.80M(+63.7%) | -$12.42M(+9.7%) | -$41.80M(+17.2%) |
| Sep 2019 | - | -$11.32M(-1.9%) | -$35.65M(+20.5%) |
| Jun 2019 | - | -$11.54M(+77.0%) | -$29.58M(+26.4%) |
| Mar 2019 | - | -$6.52M(+3.9%) | -$23.40M(-8.3%) |
| Dec 2018 | -$25.53M(+13.8%) | -$6.27M(+19.5%) | -$25.53M(+1.3%) |
| Sep 2018 | - | -$5.25M(-2.0%) | -$25.20M(+1.2%) |
| Jun 2018 | - | -$5.36M(-38.0%) | -$24.90M(-8.8%) |
| Mar 2018 | - | -$8.64M(+45.4%) | -$27.31M(+21.7%) |
| Dec 2017 | -$22.44M(+27.4%) | -$5.95M(+20.1%) | -$22.44M(+3.0%) |
| Sep 2017 | - | -$4.95M(-36.3%) | -$21.78M(-16.5%) |
| Jun 2017 | - | -$7.77M(+106.0%) | -$26.07M(+24.5%) |
| Mar 2017 | - | -$3.77M(-28.6%) | -$20.95M(+18.9%) |
| Dec 2016 | -$17.61M(+460.5%) | -$5.28M(-42.9%) | -$17.61M(+31.2%) |
| Sep 2016 | - | -$9.24M(+249.2%) | -$13.43M(-144.3%) |
| Jun 2016 | - | -$2.65M(+504.3%) | $30.31M(+99.4%) |
| Mar 2016 | - | -$438.00K(-60.0%) | $15.20M(-583.6%) |
| Dec 2015 | -$3.14M | -$1.10M(-103.2%) | -$3.14M(-85.3%) |
| Sep 2015 | - | $34.49M(-294.2%) | -$21.32M(-71.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2015 | - | -$17.76M(-5.4%) | -$74.41M(-4.1%) |
| Mar 2015 | - | -$18.77M(-2.6%) | -$77.55M(-1.9%) |
| Dec 2014 | -$79.07M(+1.1%) | -$19.27M(+3.6%) | -$79.07M(+0.6%) |
| Sep 2014 | - | -$18.60M(-11.0%) | -$78.57M(+2.6%) |
| Jun 2014 | - | -$20.90M(+3.0%) | -$76.57M(+0.8%) |
| Mar 2014 | - | -$20.29M(+8.1%) | -$75.98M(-2.8%) |
| Dec 2013 | -$78.18M(+43.1%) | -$18.77M(+13.1%) | -$78.18M(+8.6%) |
| Sep 2013 | - | -$16.60M(-18.3%) | -$72.02M(+4.5%) |
| Jun 2013 | - | -$20.31M(-9.7%) | -$68.88M(+11.6%) |
| Mar 2013 | - | -$22.49M(+78.4%) | -$61.73M(+13.0%) |
| Dec 2012 | -$54.64M(+13.9%) | -$12.61M(-6.4%) | -$54.64M(+3.3%) |
| Sep 2012 | - | -$13.47M(+2.4%) | -$52.90M(+2.7%) |
| Jun 2012 | - | -$13.16M(-14.6%) | -$51.51M(+1.9%) |
| Mar 2012 | - | -$15.40M(+41.7%) | -$50.54M(+5.3%) |
| Dec 2011 | -$47.99M(+25.2%) | -$10.87M(-10.1%) | -$47.99M(+5.8%) |
| Sep 2011 | - | -$12.08M(-0.9%) | -$45.36M(+8.6%) |
| Jun 2011 | - | -$12.19M(-5.1%) | -$41.77M(+8.2%) |
| Mar 2011 | - | -$12.85M(+56.0%) | -$38.59M(+0.7%) |
| Dec 2010 | -$38.34M(+40.6%) | -$8.24M(-3.0%) | -$38.34M(+2.8%) |
| Sep 2010 | - | -$8.49M(-5.7%) | -$37.30M(+0.6%) |
| Jun 2010 | - | -$9.01M(-28.4%) | -$37.09M(-28.3%) |
| Mar 2010 | - | -$12.59M(+74.7%) | -$51.70M(+89.6%) |
| Dec 2009 | -$27.26M(-32.0%) | -$7.21M(-13.0%) | -$27.26M(+540.6%) |
| Sep 2009 | - | -$8.28M(-64.9%) | -$4.26M(-73.8%) |
| Jun 2009 | - | -$23.62M(-299.4%) | -$16.25M(+33.6%) |
| Mar 2009 | - | $11.84M(-25.1%) | -$12.16M(-69.7%) |
| Dec 2008 | -$40.12M(-261.3%) | $15.80M(-177.9%) | -$40.12M(-446.5%) |
| Sep 2008 | - | -$20.27M(+3.8%) | $11.58M(-26.7%) |
| Jun 2008 | - | -$19.54M(+21.2%) | $15.79M(-29.6%) |
| Mar 2008 | - | -$16.11M(-123.9%) | $22.43M(-9.8%) |
| Dec 2007 | $24.87M(-145.6%) | $67.51M(-520.2%) | $24.87M(-158.3%) |
| Sep 2007 | - | -$16.07M(+24.6%) | -$42.63M(+60.5%) |
| Jun 2007 | - | -$12.90M(-5.7%) | -$26.57M(+94.3%) |
| Mar 2007 | - | -$13.67M(-3.7%) | -$13.67M(-3.7%) |
| Dec 2006 | -$54.56M(-18.3%) | - | - |
| Dec 2005 | -$66.77M(+88.7%) | - | - |
| Mar 2005 | - | -$14.20M | -$14.20M |
| Dec 2004 | -$35.39M(+45.1%) | - | - |
| Dec 2003 | -$24.38M | - | - |
FAQ
- What is Madrigal Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals annual FCF year-on-year change?
- What is Madrigal Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals quarterly FCF year-on-year change?
- What is Madrigal Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals TTM FCF year-on-year change?
What is Madrigal Pharmaceuticals annual free cash flow?
The current annual FCF of MDGL is -$462.03M
What is the all time high annual FCF for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high annual free cash flow is $24.87M
What is Madrigal Pharmaceuticals annual FCF year-on-year change?
Over the past year, MDGL annual free cash flow has changed by -$136.32M (-41.85%)
What is Madrigal Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of MDGL is -$88.89M
What is the all time high quarterly FCF for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high quarterly free cash flow is $67.51M
What is Madrigal Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, MDGL quarterly free cash flow has changed by +$60.62M (+40.55%)
What is Madrigal Pharmaceuticals TTM free cash flow?
The current TTM FCF of MDGL is -$401.41M
What is the all time high TTM FCF for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high TTM free cash flow is $30.31M
What is Madrigal Pharmaceuticals TTM FCF year-on-year change?
Over the past year, MDGL TTM free cash flow has changed by -$10.29M (-2.63%)